PBM Stock Summary and Trading Ideas (Psyence Biomedical Ltd. - | NASDAQ:PBM)

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical Ltd. - trades on the NASDAQ stock market under the symbol PBM.

As of June 28, 2024, PBM stock price declined to $0.30 with 319,808 million shares trading.

PBM has a beta of -1.33, meaning it tends to be less sensitive to market movements. PBM has a correlation of 0.00 to the broad based SPY ETF.

PBM has a market cap of $4.02 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that PBM belongs to (by Net Assets): PSIL.

PBM support price is $.30 and resistance is $.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PBM stock will trade within this expected range on the day.